Core Viewpoint - DXS International plc is preparing for its Annual General Meeting and anticipates a challenging half-year ending October 2025, with expectations of a marginal loss, but is optimistic about operational improvements in 2026 due to potential NHS funding renewal [2][3][4]. Group 1: AGM and Financial Outlook - The Annual General Meeting is scheduled for today at Elm House, Tanshire Park, and the AGM documents, including the Annual Report for the year ended April 30, 2025, are available for download [2][3]. - Current trading for the half year ending October 31, 2025, is expected to be broadly flat, with a marginal loss anticipated [3]. - The half-year results will be reported in January 2026, consistent with the previous three years [5]. Group 2: Operational Developments - The Board is optimistic that calendar year 2026 will be operationally positive, with NHS funding likely to be renewed between April and June [4]. - The company has made significant progress in development commitments, including the rebuilding of the SMART Referral solution and completion of a Cholesterol Prototype [4]. - Cost management measures are being implemented, particularly at the senior management level, to maintain cash flow [4]. Group 3: Cyber Security Incident - A separate announcement regarding a Cyber Security Incident was made, detailing the steps taken by the company in response [5]. Group 4: Company Overview - DXS International provides healthcare information and digital clinical decision support systems, aiming to improve healthcare outcomes and contribute to NHS efficiency savings [7].